Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 14/20 | 0.52 |
| ▸ | CES1 | P23141 | 10/20 | 0.50 |
| ▸ | CES2 | O00748 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | PLA2G4C | Q9UP65 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7252679 | 0.86 | FAAH (0.59) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL1347562 | 0.85 | FAAH (0.69) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL11218026 | 0.83 | FAAH (0.70) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL20905096 | 0.83 | FAAH (0.70) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL11214076 | 0.83 | FAAH (0.70) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL11211125 | 0.83 | FAAH (0.70) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL9770770 | 0.83 | FAAH (0.70) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL5466926 | 0.83 | FAAH (0.70) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL18319323 | 0.83 | FAAH (0.70) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL31182126 | 0.82 | FAAH (0.38) | FAAHCES1CES2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4322441-A | Use of fluorinated beta-diketones as bacteriocides and fungicides | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1982-03-30 | — | — | US | claimed |
| US-20170253623-A1 | IRIDIUM COMPLEX PRODUCTION METHOD | TANAKA KIKINZOKU KOGYO K.K. (JP) | 2017-09-07 | — | — | US | disclosed |
| US-20170253623-A1 | IRIDIUM COMPLEX PRODUCTION METHOD | TANAKA KIKINZOKU KOGYO K.K. (JP) | 2017-09-07 | — | — | US | disclosed |
| US-20050107372-A1 | 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators | LANTER JAMES C (US) | 2005-05-19 | — | — | US | disclosed |
| US-6858621-B2 | 2-(quinolonyl)-fused heterocycles as androgen receptor modulators | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2005-02-22 | — | — | US | disclosed |
| US-20040014743-A1 | 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2004-01-22 | — | — | US | disclosed |
| US-4322441-A | Use of fluorinated beta-diketones as bacteriocides and fungicides | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1982-03-30 | — | — | US | disclosed |
| US-4320149-A | Use of fluorinated beta-diketones as antiplaque agents | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1982-03-16 | — | — | US | disclosed |
| US-4180386-A | ANTIKNOCK FUEL ADDITIVES | E. I. DU PONT DE NEMOURS & COMPANY (US) | 1979-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014743-A1 | 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators | AR, NR5A1, ESRRA | FAAH 2662/4885CES1 1031/4885CES2 2577/4885 |
| US-20050107372-A1 | 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators | AR, NR5A1, CYP19A1 | FAAH 3191/4885CES1 1328/4885CES2 2546/4885 |
| US-20170253623-A1 | IRIDIUM COMPLEX PRODUCTION METHOD | IPMK, TALDO1, BCKDK | FAAH 3210/4885CES1 2112/4885CES2 3625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.